Screening for SARS-CoV-2 non-structural protein 14 inhibitors

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) genome generates 16 distinct non-structural proteins (nsp) that constitute the enzymes and

Read more

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

In a recent quest for an effective antiviral compound, UK researchers have purified a specific enzyme of the severe acute

Read more

Study identifies immune profile of people with severe COVID-19

A team of researchers at Georgetown University Medical Center, USA, investigated how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) affects

Read more

Elevated Activin A and FLRG levels correlate with worst outcomes in severe COVID-19

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a "cytokine storm" in hospitalized and ICU patients. Studies have shown

Read more

Intelence

NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. INTELENCE® (170905) ACMI etravirine Consumer Medicine Information

Read more